RxDoctor Payments Data

Annie Park

Hospitalist · Canton, GANPI 1194165944

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.3% of the total across 1,058 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations. Among hospitalist clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,903in general payments, 2019–2025

Across 1,058 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$2K
  • AstraZeneca$1K
  • Biohaven Pharmaceuticals, Inc.$1K
  • Novo Nordisk$1K
  • Amarin Pharma, Inc.$766
  • plus $10K from 54 others

What the payments were for

  • Consulting fees$1,2006%
  • Food & beverage$17,44692%
  • Education$2581%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)183$2,384
Amgen(2 entities)86$1,667
AstraZeneca83$1,367
Biohaven Pharmaceuticals, Inc.2$1,217
Novo Nordisk65$1,128
Amarin Pharma, Inc.43$766
Pfizer34$611
Astellas Pharma US Inc27$594
Scilex Pharmaceuticals Inc.29$579
Lilly USA, LLC34$510
Sanofi-aventis U.S. LLC25$478
Sumitomo Pharma America, Inc.37$468
Boehringer Ingelheim28$461
Johnson & Johnson29$439
Optinose US, Inc.27$428
Gilead19$371
Dexcom, Inc.13$348
GSK21$333
Bayer18$312
Paratek Pharmaceuticals, Inc.15$298
Merck20$293
Arbor Pharmaceuticals, Inc.17$275
Eisai Inc.18$260
Aimmune Therapeutics, Inc.11$225
Ardelyx, Inc.10$207
IBSA Pharma Inc.16$189
Otsuka America Pharmaceutical, Inc.4$189
Vivus LLC11$181
Kowa Pharmaceuticals America, Inc.12$173
Nestle Healthcare Nutrition Inc.9$161
Novartis10$149
Biohaven Pharmaceutical Holding Company Ltd.11$144
Corcept Therapeutics6$137
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$135
Upsher-smith Laboratories LLC5$134
Exact Sciences8$126
Abbott6$120
Takeda Pharmaceuticals U.S.A., Inc.7$116
Lundbeck LLC5$115
Esperion Therapeutics, Inc.6$103
Azurity Pharmaceuticals, Inc.4$82
VBI Vaccine (delaware) Inc.3$63
Corium, LLC3$62
Radius Health, Inc.3$61
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$56
Mylan Specialty L.p.3$55
Teva Pharmaceuticals USA, Inc.3$40
Medtronic2$38
Axsome Therapeutics, Inc.2$32
Sunovion Pharmaceuticals Inc.3$29
Cequr Corporation2$28
Vanda Pharmaceuticals Inc.1$24
Xeris Pharmaceuticals, Inc.1$21
Jazz Pharmaceuticals Inc.1$20
Daiichi Sankyo Inc.1$18
Almatica Pharma LLC1$16
Phathom Pharmaceuticals, Inc.1$15
Ironwood Pharmaceuticals, Inc1$13
Digestive Care, Inc.1$13
Theracosbio, LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,903 in reported general payments places this provider in the 95th percentile of 812 hospitalist providers in Georgia.

See all hospitalist providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol27$37,394
OzempicSemaglutide29$37,192
VascepaIcosapent Ethyl41$31,545
ProliaDenosumab15$25,941
JanuviaSitagliptin Phosphate20$19,116
MounjaroTirzepatide16$18,721
CreonLipase/Protease/Amylase13$17,402
ZtlidoLidocaine23$17,378
GemtesaVibegron20$16,716
RybelsusSemaglutide11$13,335
Lidocaine58$12,468
DayvigoLemborexant11$3,702
Diclofenac Sodium57$3,272
ShingrixVaricella-Zoster Ge/As01b/Pf15$3,230
Boostrix TdapDiphth,pertuss(Acell),tet Vac28$1,832

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,128$50,52740 claims
AstraZenecaFarxiga$1,367$37,39427 claims
AmgenProlia$1,667$25,94115 claims
MerckJanuvia$293$19,11620 claims
Lilly USA, LLCMounjaro$510$18,72116 claims
AbbVieCreon$2,384$17,40213 claims
Scilex Pharmaceuticals Inc.Ztlido$579$17,37823 claims
Sumitomo Pharma America, Inc.Gemtesa$468$16,71620 claims
Eisai Inc.Dayvigo$260$3,70211 claims
GSKShingrix$333$3,23015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 812 hospitalist providers in Georgia.

Other hospitalist in Canton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →